Table 2 Subgroup analyses for the effects of omega-3 supplementation on cognitive function.
From: A systematic review and dose response meta analysis of Omega 3 supplementation on cognitive function
Effect size, n | SMD (95% CI)1 | P-within2 | I2 (%)3 | P-heterogeneity4 | P-between5 | |
---|---|---|---|---|---|---|
Attention outcome | ||||||
Overall | 32 | 0.117 (-0.958, 1.193) | 0.831 | 98.5 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 26 | 25 | -0.054 (-0.211, 0.102) | 0.498 | 92.5 | < 0.001 | |
26≤ | 7 | 0.456 (0.248, 0.665) | 0.001 | 99.6 | < 0.001 | |
Age (years) | 0.684 | |||||
< 60 | 13 | 0.093 (-0.125, 0.310) | 0.403 | 74.1 | < 0.001 | |
60≤ | 19 | 0.148 (-0.005, 0.301) | 0.058 | 99.1 | < 0.001 | |
Location | 0.001 | |||||
America | 15 | -0.098 (-0.301, 0.105) | 0.344 | 94.5 | < 0.001 | |
Europe | 10 | -0.153 (-0.353, 0.047) | 0.135 | 99.4 | < 0.001 | |
Asia and Oceania | 7 | 0.981 (0.720, 1.241) | 0.001 | 95.5 | < 0.001 | |
Health status | 0.141 | |||||
Healthy | 20 | 0.029 (-0.153, 0.212) | 0.752 | 94.9 | < 0.001 | |
Cognitive disorders | 12 | 0.218 (0.046, 0.389) | 0.013 | 99.3 | < 0.001 | |
BMI | 0.001 | |||||
Normal | 27 | -0.028 (-0.186, 0.130) | 0.726 | 93.4 | < 0.001 | |
Over weight | 5 | 0.394 (0.190, 0.599) | 0.001 | 99.8 | < 0.001 | |
Assessment tool | 0.001 | |||||
TMT A | 10 | -0.081 (-0.259, 0.096) | 0.370 | 99.5 | < 0.001 | |
Stroop | 14 | 0.725 (0.439, 1.011) | 0.001 | 93.8 | < 0.001 | |
Other tools | 8 | 0.099 (-0.126, 0.323) | 0.388 | 61.9 | 0.010 | |
Co-intervention | 0.001 | |||||
Yes | 10 | 0.469 (0.291, 0.648) | 0.001 | 92.3 | 0.010 | |
No | 22 | -0.199 (-0.375, -0.024) | 0.026 | 99.5 | < 0.001 | |
Executive function outcome | ||||||
Overall | 39 | 0.520 (-0.159, 1.212) | 0.132 | 98.6 | < 0.001 | |
Intervention duration (weeks) | 0.003 | |||||
< 48 | 29 | 0.384 (0.286, 0.482) | 0.001 | 97.2 | < 0.001 | |
48≤ | 10 | 0.162 (0.043, 0.282) | 0.008 | 99.5 | < 0.001 | |
Age (years) | 0.405 | |||||
< 49 | 4 | 0.235 (0.062, 0.409) | 0.008 | 76.6 | 0.005 | |
49≤ | 35 | 0.309 (0.225, 0.393) | 0.001 | 98.7 | < 0.001 | |
Location | 0.001 | |||||
America | 12 | 0.062 (-0.046, 0.171) | 0.259 | 97.8 | < 0.001 | |
Europe | 15 | 0.287 (0.160, 0.413) | 0.001 | 99.3 | < 0.001 | |
Asia and Oceania | 12 | 1.074 (0.878, 1.269) | 0.001 | 95.3 | < 0.001 | |
Health status | 0.001 | |||||
Healthy | 25 | 0.213 (0.125, 0.301) | 0.001 | 97.6 | < 0.001 | |
Cognitive disorders | 14 | 0.530 (0.381, 0.679) | 0.001 | 99.2 | < 0.001 | |
BMI | 0.001 | |||||
Normal | 14 | -0.371 (-0.583, -0.158) | 0.001 | 95.7 | < 0.001 | |
Over weight | 25 | 0.399 (0.318, 0.480) | 0.001 | 99.0 | < 0.001 | |
Sex | 0.001 | |||||
Males and females | 34 | 0.319 (0.242, 0.396) | 0.001 | 98.7 | < 0.001 | |
Females | 5 | -0.482 (-0.917, -0.048) | 0.03 | 48.4 | 0.10 | |
Assessment tool | 0.001 | |||||
TMT B | 12 | 0.531 (0.384, 0.679) | 0.001 | 99.5 | < 0.001 | |
Stroop | 6 | 0.332 (0.132, 0.533) | 0.001 | 93.6 | < 0.001 | |
Other tools | 21 | 0.192 (0.090, 0.290) | 0.001 | 93.8 | < 0.001 | |
Co-intervention | 0.001 | |||||
Yes | 14 | -0.038 (-0.153, 0.077) | 0.515 | 99.2 | < 0.001 | |
No | 26 | 0.560 (0.460, 0.661) | 0.001 | 97.6 | < 0.001 | |
Perceptual speed outcome | ||||||
Overall | 34 | 0.444 (-0.014, 0.901) | 0.057 | 96.4 | < 0.001 | |
Intervention duration (weeks) | 0.075 | |||||
< 48 | 20 | 0.478 (0.367, 0.590) | 0.001 | 96.9 | < 0.001 | |
48≤ | 14 | 0.350 (0.241, 0.460) | 0.001 | 95.6 | < 0.001 | |
Age (years) | 0.001 | |||||
< 60 | 12 | 0.619 (0.492, 0.747) | 0.001 | 98.0 | < 0.001 | |
60≤ | 22 | 0.290 (0.191, 0.388) | 0.001 | 93.9 | < 0.001 | |
Location | 0.006 | |||||
Asia and Oceania | 17 | 0.570 (0.425, 0.716) | 0.001 | 95.8 | < 0.001 | |
Europe and America | 17 | 0.350 (0.257, 0.442) | 0.001 | 97.0 | < 0.001 | |
Health status | 0.020 | |||||
Healthy | 22 | 0.491 (0.393, 0.590) | 0.001 | 96.3 | < 0.001 | |
Cognition disorders | 12 | 0.279 (0.150, 0.408) | 0.001 | 96.7 | < 0.001 | |
BMI | 0.676 | |||||
Normal | 16 | 0.413 (0.206, 0.619) | 0.001 | 97.0 | < 0.001 | |
Over weight | 18 | 0.413 (0.329, 0.498) | 0.001 | 95.8 | < 0.001 | |
Sex | 0.001 | |||||
Males and females | 31 | 0.421 (0.343, 0.499) | 0.001 | 98.3 | < 0.001 | |
Males | 3 | -3.871 (-5.694, -2.049) | 0.001 | 96.1 | < 0.001 | |
Co-intervention | 0.001 | |||||
Yes | 9 | -0.131 (-0.286, 0.024) | 0.099 | 98.0 | < 0.001 | |
No | 25 | 0.598 (0.507, 0.688) | 0.001 | 94.7 | < 0.001 | |
Language outcome | ||||||
Overall | 26 | 0.976 (0.413, 1.539) | 0.001 | 96.8 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 48 | 12 | 0.784 (0.654, 0.914) | 0.001 | 97.9 | < 0.001 | |
48≤ | 14 | -0.161 (-0.282, -0.039) | 0.010 | 91.6 | < 0.001 | |
Age (years) | 0.001 | |||||
< 60 | 3 | 0.838 (0.688, 0.989) | 0.001 | 99.5 | < 0.001 | |
60≤ | 23 | -0.018 (-0.129, 0.092) | 0.744 | 92.3 | < 0.001 | |
Location | 0.001 | |||||
Europe and America | 16 | 0.401 (0.293, 0.508) | 0.001 | 97.8 | < 0.001 | |
Asia and Oceania | 10 | 0.022 (-0.136, 0.180) | 0.785 | 87.2 | < 0.001 | |
Health status | 0.001 | |||||
Healthy | 12 | 0.540 (0.414, 0.667) | 0.001 | 98.2 | < 0.001 | |
Cognitive disorders | 14 | 0.030 (-0.095, 0.155) | 0.638 | 91.0 | < 0.001 | |
BMI | 0.001 | |||||
Normal | 12 | 1.073 (0.762, 1.383) | 0.001 | 97.8 | < 0.001 | |
Over weight | 14 | 0.210 (0.117, 0.303) | 0.001 | 94.8 | < 0.001 | |
Assessment tool | 0.001 | |||||
Verbal fluency | 6 | -0.476 (-0.778, -0.175) | 0.002 | 95.9 | < 0.001 | |
Other tools | 20 | 0.353 (0.260, 0.446) | 0.001 | 97.0 | < 0.001 | |
Co-intervention | 0.001 | |||||
Yes | 10 | 0.043 (-0.135, 0.222) | 0.001 | 97.9 | < 0.001 | |
No | 16 | 0.359 (0.257, 0.462) | 0.001 | 95.5 | < 0.001 | |
Episodic memory outcome | ||||||
Overall | 103 | 0.265 (-0.058, 0.588) | 0.108 | 92.9 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 48 | 86 | 0.423 (0.337, 0.508) | 0.001 | 83.9 | < 0.001 | |
48≤ | 17 | -0.286 (-0.405, -0.167) | 0.001 | 98.1 | < 0.001 | |
Age (years) | 0.001 | |||||
< 60 | 31 | 0.532 (0.430, 0.634) | 0.001 | 82.8 | < 0.001 | |
60≤ | 72 | -0.119 (-0.213, -0.024) | 0.014 | 94.0 | < 0.001 | |
Location | 0.001 | |||||
America | 40 | 0.373 (0.283, 0.463) | 0.001 | 82.6 | < 0.001 | |
Europe | 42 | -0.255 (-0.375, -0.136) | 0.001 | 95.5 | < 0.001 | |
Asia and Oceania | 21 | 0.659 (0.392, 0.927) | 0.001 | 90.8 | < 0.001 | |
Health status | 0.001 | |||||
Healthy | 69 | 0.280 (0.202, 0.357) | 0.001 | 90.3 | < 0.001 | |
Cognitive disorders | 34 | -0.211 (-0.366, -0.055) | 0.008 | 95.4 | < 0.001 | |
BMI | 0.451 | |||||
Normal | 63 | 0.231 (0.086, 0.375) | 0.002 | 85.1 | < 0.001 | |
Over weight | 40 | 0.167 (0.088, 0.246) | 0.001 | 96.2 | < 0.001 | |
Sex 0.153 | ||||||
Males and females | 90 | 0.187 (0.118, 0.257) | 0.001 | 93.5 | < 0.001 | |
Females | 13 | -0.282 (-0.922, 0.358) | 0.387 | 82.4 | < 0.001 | |
Co-intervention | 0.001 | |||||
Yes | 23 | -0.258 (-0.373, -0.143) | 0.001 | 96.8 | < 0.001 | |
No | 80 | 0.434 (0.347, 0.521) | 0.001 | 88.1 | < 0.001 | |
Primary memory outcome | ||||||
Overall | 20 | 0.768 (0.059, 1.477) | 0.034 | 96.2 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 48 | 13 | 0.189 (-0.028, 0.407) | 0.021 | 63.0 | < 0.001 | |
48≤ | 7 | 1.144 (0.984, 1.304) | 0.001 | 98.6 | < 0.001 | |
Location | 0.001 | |||||
America | 2 | 0.610 (0.018, 1.201) | 0.043 | 0.0 | 0.829 | |
Europe | 10 | -0.054 (-0.213, 0.106) | 0.509 | 60.6 | 0.007 | |
Asia and Oceania | 8 | 2.718 (2.483, 2.953) | 0.001 | 94.0 | < 0.001 | |
Health status | 0.001 | |||||
Healthy | 15 | 0.004 (-0.149, 0.158) | 0.955 | 55.2 | 0.005 | |
Cognitive disorders | 5 | 2.741 (2.503, 2.978) | 0.001 | 96.5 | < 0.000 | |
BMI | 0.405 | |||||
Normal | 6 | 1.054 (0.466, 1.642) | 0.001 | 8.3 | 0.363 | |
Over weight | 14 | 0.797 (0.665, 0.929) | 0.001 | 97.4 | < 0.001 | |
Assessment tool | 0.001 | |||||
Digit span | 15 | 0.972 (0.822, 1.120) | 0.001 | 97.0 | < 0.001 | |
Other tools (recall) | 5 | 0.372 (0.112, 0.631) | 0.005 | 0.0 | 0.848 | |
Co-intervention | 0.001 | |||||
Yes | 5 | -0.126 (-0.461, 0.209) | 0.460 | 55.5 | 0.061 | |
No | 15 | 0.972 (0.833, 1.112) | 0.001 | 97.0 | 0.001 | |
Visuospatial functions outcome | ||||||
Overall | 15 | 0.893 (0.452, 1.333) | 0.001 | 97.4 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 48 | 6 | 2.038 (1.739, 2.338) | 0.001 | 98.0 | < 0.001 | |
48≤ | 9 | 0.364 (0.295, 0.433) | 0.001 | 95.1 | < 0.001 | |
Location | 0.001 | |||||
America and Europe | 3 | 4.236 (3.768, 4.703) | 0.001 | 98.1 | < 0.001 | |
Asia | 12 | 0.368 (0.300, 0.436) | 0.001 | 93.4 | < 0.001 | |
Health status | 0.001 | |||||
Healthy | 3 | 4.236 (3.768, 4.703) | 0.001 | 98.1 | < 0.001 | |
Cognitive disorders | 12 | 0.368 (0.300, 0.436) | 0.001 | 93.4 | < 0.001 | |
BMI | 0.001 | |||||
Normal | 6 | 2.038 (1.739, 2.338) | 0.001 | 98.0 | < 0.001 | |
Over weight | 9 | 0.364 (0.295, 0.433) | 0.001 | 95.1 | < 0.001 | |
Assessment tool | 0.001 | |||||
Block design | 4 | 0.041 (-0.080, 0.171) | 0.482 | 37.5 | 0.171 | |
Picture arrangement | 3 | 0.122 (-0.002, 0.253) | 0.059 | 87.8 | < 0.001 | |
Picture completion | 3 | 0.881 (0.747, 1.032) | 0.001 | 81.7 | 0.001 | |
Other tools | 5 | 0.852 (0.712, 0.980) | 0.001 | 98.9 | < 0.001 | |
Co-intervention | 0.001 | |||||
Yes | 1 | 2.735 (2.033, 3.437) | 0.001 | - | - | |
No | 14 | 0.427 (0.360, 0.495) | 0.001 | 97.3 | < 0.001 | |
Global cognitive ability outcome | ||||||
Overall | 60 | 1.001 (0.650, 1.353) | 0.001 | 97.1 | < 0.001 | |
Intervention duration (weeks) | 0.001 | |||||
< 48 | 33 | 0.276 (0.168, 0.383) | 0.001 | 93.4 | < 0.001 | |
48≤ | 27 | -0.137 (-0.203, -0.071) | 0.001 | 98.3 | < 0.001 | |
Age (years) | 0.014 | |||||
< 60 | 10 | 0.173 (0.012, 0.335) | 0.036 | 62.7 | 0.004 | |
60≤ | 50 | -0.041 (-0.101, 0.012) | 0.161 | 97.4 | < 0.001 | |
Location | 0.001 | |||||
America | 17 | -0.469 (-0.555, -0.384) | 0.001 | 96.1 | < 0.001 | |
Europe | 17 | 0.214 (0.112, 0.315) | 0.001 | 73.1 | < 0.001 | |
Asia and Oceania | 26 | 0.463 (0.341, 0.565) | 0.001 | 98.2 | < 0.001 | |
Health status | 0.011 | |||||
Healthy | 19 | 0.071 (-0.021, 0.163) | 0.131 | 96.3 | < 0.001 | |
Cognitive disorders | 41 | -0.079 (-0.151, -0.008) | 0.029 | 97.4 | < 0.001 | |
BMI | 0.001 | |||||
Normal | 30 | 0.322 (0.207, 0.437) | 0.001 | 96.4 | < 0.001 | |
Over weight | 30 | -0.131 (-0.196, -0.067) | 0.001 | 97.5 | < 0.001 | |
Co-intervention | 0.002 | |||||
Yes | 15 | 0.141 (0.026, 0.255) | 0.016 | 96.8 | < 0.001 | |
No | 45 | -0.075 (-0.140, -0.011) | 0.022 | 97.2 | < 0.001 |